Discovery of antiproliferative and anti-FAK inhibitory activity of 1,2,4-triazole derivatives containing acetamido carboxylic acid skeleton

Autor: Pradipta Ghosh, Alaa M. Hayallah, Esam R. Ahmed, Muhamad Mustafa, Gamal El-Din A. Abuo-Rahma, Amer Ali Abd El-Hafeez, Dalia Abdelhamid
Rok vydání: 2021
Předmět:
Cell cycle checkpoint
Clinical Biochemistry
Pharmaceutical Science
Apoptosis
Drug Screening Assays
01 natural sciences
Biochemistry
Anticancer activity
Synthesis
Drug Discovery
Aminobenzoates
Phosphorylation
Cancer
Tumor
medicine.diagnostic_test
Kinase
Chemistry
FAK inhibitors
Pharmacology and Pharmaceutical Sciences
Molecular Docking Simulation
5.1 Pharmaceuticals
S Phase Cell Cycle Checkpoints
Molecular Medicine
Development of treatments and therapeutic interventions
Docking study
Protein Binding
Medicinal & Biomolecular Chemistry
Antineoplastic Agents
Article
Cell Line
Focal adhesion
Medicinal and Biomolecular Chemistry
Rare Diseases
Western blot
Cell Line
Tumor

4-triazoles
medicine
Humans
Molecular Biology
Protein kinase B
IC50
Protein Kinase Inhibitors
PI3K/AKT/mTOR pathway
Cell Proliferation
5-Pyridinyl-1
Binding Sites
010405 organic chemistry
Organic Chemistry
Antitumor
Triazoles
G1 Phase Cell Cycle Checkpoints
0104 chemical sciences
010404 medicinal & biomolecular chemistry
Focal Adhesion Kinase 1
Cancer research
Acetanilides
Drug Screening Assays
Antitumor
Zdroj: Bioorg Med Chem Lett
Popis: Small molecule inhibitors of the focal adhesion kinase are regarded as promising tools in our armamentarium for treating cancer. Here, we identified four 1,2,4-triazole derivatives that inhibit FAK kinase significantly and evaluated their therapeutic potential. Most tested compounds revealed potent antiproliferative activity in HepG2 and Hep3B liver cancer cells, in which 3c and 3d were the most potent (IC50 range; 2.88~4.83µM). Compound 3d possessed significant FAK inhibitory activity with IC50 value of 18.10nM better than the reference GSK-2256098 (IC50=22.14nM). The preliminary mechanism investigation by Western blot analysis showed that both 3c and 3d repressed FAK phosphorylation comparable to GSK-2256098 in HepG2 cells. As a result of FAK inhibition, 3c and 3d inhibited the pro-survival pathways by decreasing the phosphorylation levels of PI3K, Akt, JNK, and STAT3 proteins. This effect led to apoptosis induction and cell cycle arrest. Taken together, these results indicate that 3d could serve as a potent preclinical candidate for the treatment of cancers.
Databáze: OpenAIRE